StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a report issued on Tuesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Down 0.2 %
AEZS opened at $5.86 on Tuesday. The stock’s 50 day moving average price is $5.61 and its two-hundred day moving average price is $7.13. The firm has a market capitalization of $10.51 million, a P/E ratio of -0.39 and a beta of 1.55. Aeterna Zentaris has a 12-month low of $3.96 and a 12-month high of $12.00.
About Aeterna Zentaris
See Also
- Five stocks we like better than Aeterna Zentaris
- Basic Materials Stocks Investing
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- Why Are Stock Sectors Important to Successful Investing?
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- How to Effectively Use the MarketBeat Ratings Screener
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.